Kristopher L. Hanson - 05 Feb 2026 Form 4 Insider Report for MapLight Therapeutics, Inc. (MPLT)

Reporting relationship: General Counsel
Issuer ticker: MPLT
Reported as of: 05 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Feb 2026, 17:50:08 UTC
Prior SEC filing: 29 Jan 2026
Next SEC filing: 17 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Kristopher L. Hanson

Key filing fact

Kristopher L. Hanson filed Form 4 for MapLight Therapeutics, Inc. (MPLT) on 09 Feb 2026.

Key facts

This page summarizes Kristopher L. Hanson's Form 4 filing for MapLight Therapeutics, Inc. (MPLT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 09 Feb 2026, 17:50.

Change

Previous filing in this sequence was filed on 29 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001789970 Primary reporting owner

Hanson Kristopher

Relationship: General Counsel
Address: C/O MAPLIGHT THERAPEUTICS, INC., 800 CHESAPEAKE DRIVE, REDWOOD CITY
Signature: /s/ Kristopher L. Hanson
Signature date: 09 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MPLT transaction

Voting Common Stock

Award

Transaction value: $0
Shares: +7,730
Change %: +4.2%
Price: $0.000000
Shares after: 191,582
Date: 05 Feb 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MPLT transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +31,395
Change %
Price: $0.000000
Shares after: 31,395
Date: 05 Feb 2026
Ownership: Direct
Underlying class: Voting Common Stock
Underlying amount: 31,395
Exercise price: $15.70
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on January 1, 2027, and 1/16th of the RSUs shall vest on each subsequent April 1, July 1, October 1 and January 1 thereafter, subject to the Reporting Person's continued service through each vesting date.

Footnote F2

Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Footnote F3

1/4th of the total shares underlying the option shall vest on February 5, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.